Literature DB >> 26765551

Carboxyhemoglobin levels as a predictor of risk for significant hyperbilirubinemia in African-American DAT(+) infants.

D L Schutzman1, E Gatien2, S Ajayi3, R J Wong4.   

Abstract

OBJECTIVES: To compare the degree of hemolysis in a group of direct antiglobulin test (DAT) positive (pos) African-American (AA) infants as measured by carboxyhemoglobin corrected (COHbc) for carbon monoxide in ambient air to a similar group of DAT negative (neg) ABO incompatible infants and a group without blood group incompatibility. To determine if COHbc is a better predictor of significant hyperbilirubinemia than DAT status. STUDY
DESIGN: A prospective study of 180 AA infants from the Well-Baby Nursery of an inner city community hospital, all of whose mothers were type O pos. Infants (60) were ABO incompatible DAT pos, 60 were ABO incompatible DAT neg and 60 were type O(+). Blood for COHbc was drawn at the time of the infants' initial bilirubin and the infants' precise percentile on the Bhutani nomogram was calculated. RESULT: Mean COHbc of type O(+) infants was 0.76±0.21 and 0.78±0.24% for ABO incompatible DAT neg infants (P=0.63). Mean CoHbc for the ABO incompatible DAT pos infants was 1.03±0.41% (P<0.0001 compared with both type O and DAT neg infants). Optimal cutoff on the receiver operating characteristic curve for COHbc to determine the risk for being in the Bhutani curve high risk zone was COHbc >0.90% (area under the curve(AUC) 0.8113). This was similar to the AUC of the receiver operating characteristic curve using any titer strength of DAT pos as a cutoff (0.7960).
CONCLUSION: Although not greatly superior to the titer strength of DAT pos, COHbc is useful in determining if the etiology of severe hyperbilirubinemia is a hemolytic process.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26765551     DOI: 10.1038/jp.2015.206

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  16 in total

1.  Evaluation of the direct antiglobulin (Coombs') test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs' test with ETCOc for detecting significant jaundice.

Authors:  Marguerite Herschel; Theodore Karrison; Ming Wen; Leslie Caldarelli; Beverly Baron
Journal:  J Perinatol       Date:  2002 Jul-Aug       Impact factor: 2.521

2.  Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

Authors:  Michael Kaplan; Cathy Hammerman; Hendrik J Vreman; Ronald J Wong; David K Stevenson
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

3.  Prediction of hyperbilirubinemia in near-term and term infants.

Authors:  D K Stevenson; A A Fanaroff; M J Maisels; B W Young; R J Wong; H J Vreman; J R MacMahon; C Y Yeung; D S Seidman; R Gale; W Oh; V K Bhutani; L H Johnson; M Kaplan; C Hammerman; H Nakamura
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

Review 4.  A global need for affordable neonatal jaundice technologies.

Authors:  Tina M Slusher; Alvin Zipursky; Vinod K Bhutani
Journal:  Semin Perinatol       Date:  2011-06       Impact factor: 3.300

5.  Bilirubin-induced neurologic dysfunction (BIND).

Authors:  Vinod K Bhutani; Ronald Wong
Journal:  Semin Fetal Neonatal Med       Date:  2015-01-07       Impact factor: 3.926

6.  Hour-specific bilirubin nomogram in infants with ABO incompatibility and direct Coombs-positive results.

Authors:  David L Schutzman; Romal Sekhon; Shilpa Hundalani
Journal:  Arch Pediatr Adolesc Med       Date:  2010-12

7.  Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates.

Authors:  Marguerite Herschel; Theodore Karrison; Ming Wen; Leslie Caldarelli; Beverly Baron
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

8.  Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice.

Authors:  Michael Kaplan; Maurizio Muraca; Cathy Hammerman; Firmino F Rubaltelli; Maria T Vilei; Hendrik J Vreman; David K Stevenson
Journal:  Pediatrics       Date:  2002-10       Impact factor: 7.124

9.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Authors:  E Beutler; T Gelbart; A Demina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.

Authors:  V K Bhutani; L Johnson; E M Sivieri
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

View more
  1 in total

1.  Effect of genetic variants of bilirubin metabolism on the degree of hyperbilirubinemia in African-American newborns.

Authors:  D L Schutzman; L M Baudhuin; E Gatien; S Ajayi; R J Wong
Journal:  J Perinatol       Date:  2016-12-15       Impact factor: 2.521

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.